I'm absolutely thrilled that this we're clearly going to have the best conversation in the fireside chat that we've had so far. Incredibly pleased to have Emma Walmsley here. She's CEO and on the ...

Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: GSK plc 2024" company profile has been added to ResearchAndMarkets.com's offering. GSK plc (GSK) is a healthcare ...

GSK has agreed to acquire full global rights to a potential best-in-class trispecific T-cell engager from Chimagen Biosciences in a transaction worth up to $750 million, expanding the pharmaceutical ...

Emma Walmsley, GSK CEO, joins CNBC's 'Squawk on the Street' to discuss the company's most recent earnings, innovation pipeline, the potential impact of tariffs on pharmaceuticals, and much more. Got a ...

GSK gained rights to a Hutchmed antibody-targeted therapy conjugate, or ATTC. This new type of targeted therapy blocks two cancer-driving proteins and will initially be developed for lung, colorectal, ...

PIIRC serves as a catalyst for innovation by supporting interdisciplinary research and real-world evidence generation focused on improving vaccine access, delivery and education. MISSISSAUGA, ON, June ...

GSK plc is returning to China for another oncology asset, agreeing to acquire global rights to a preclinical trispecific T-cell engager from Chimagen Biosciences in a deal worth up to $750 million.

GSK to acquire potential best-in-class T cell-engager (TCE) for multiple myeloma from Chimagen Biosciences. Trispecific TCE targeting T cells ...

GlaxoSmithKline has expanded its “Target the Future” campaign to include the “Think Tank Challenge.” The competition, open to individuals, advocacy groups and anyone/everyone else, will award £70,000 ...

In GSK’s second-quarter earnings discussions, the company presented itself as a “new focused biopharma company.” It’s the first call since the July 18 demerger of its consumer health unit, now dubbed ...

PHILADELPHIA--(BUSINESS WIRE)--GSK plc today announced the first recipient of the Target the Future Think Tank Challenge £70,000 (equivalent to approximately $100,000) grant to the HealthTree ...

Shortly after finding success with a digital collaboration combining the expertise of universities and major pharma players like AstraZeneca and GSK, the United Kingdom’s Centre for Process Innovation ...